Dr. Jonathan Harris oversees Caron’s Integrative Neurofeedback Therapy programs in Pennsylvania and Florida, implementing strategies to enhance patient treatment efficacy through the use of brain imaging technology. He also conducts research in collaboration with leading universities, including Stanford, Brown, and Penn State College of Medicine, to examine how neuroscience can impact the fields of addiction and mental health to improve clinical outcomes. Dr. Harris believes that advances in neuroscience promise innovative approaches to the treatment of substance use disorders, including improved targets for individualized treatment and objective measures of treatment progress.
Dr. Harris joined Caron in 2016 to lead the establishment of integrative neurofeedback therapy at Caron Pennsylvania. He completed his Ph.D. in Neuroscience at the Pennsylvania State University, College of Medicine. As part of his doctoral program, Dr. Harris was a TL1 Scholar for the Clinical and Translational Science Institute (CTSI) at Penn State, which works to bridge the gap between research science and clinical practice. That experience enabled him to study the clinical utility of implementing brain-based measures in real-world treatment settings.
During his Ph.D. program, Dr. Harris conducted neuroimaging research at Caron to investigate whether brain function could predict future relapse in patients with alcohol use disorders. He is a contributing author on scientific articles published in the Journal of Addiction Medicine and Brain Research Bulletin, and has presented his research at several scientific conferences, including the Society for Neuroscience and the Research Society on Alcoholism.